Gloeckner Christian Johannes, Kinkl Norbert, Schumacher Annette, Braun Ralf J, O'Neill Eric, Meitinger Thomas, Kolch Walter, Prokisch Holger, Ueffing Marius
GSF-National Research Center for Environment and Health, Institute of Human Genetics, Munich-Neuherberg, Germany.
Hum Mol Genet. 2006 Jan 15;15(2):223-32. doi: 10.1093/hmg/ddi439. Epub 2005 Dec 1.
Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) have been recently identified in families with autosomal dominant late-onset Parkinson disease (PD). The LRRK2 protein consists of multiple domains and belongs to the Roco family, a novel group of the Ras/GTPase superfamily. Besides the GTPase (Roc) domain, it contains a predicted kinase domain, with homology to MAP kinase kinase kinases. Using cell fractionation and immunofluorescence microscopy, we show that LRRK2 is localized in the cytoplasm and is associated with cellular membrane structures. The purified LRRK2 protein demonstrates autokinase activity. The disease-associated I2020T mutant shows a significant increase in autophosphorylation of approximately 40% in comparison to wild-type protein in vitro. This suggests that the pathology of PD caused by the I2020T mutation is associated with an increase rather than a loss in LRRK2 kinase activity.
富含亮氨酸重复激酶2基因(LRRK2)的突变最近在常染色体显性晚发性帕金森病(PD)家族中被发现。LRRK2蛋白由多个结构域组成,属于Roco家族,是Ras/GTP酶超家族中的一个新类别。除了GTP酶(Roc)结构域外,它还包含一个预测的激酶结构域,与丝裂原活化蛋白激酶激酶激酶具有同源性。通过细胞分级分离和免疫荧光显微镜检查,我们发现LRRK2定位于细胞质中,并与细胞膜结构相关。纯化的LRRK2蛋白显示出自激酶活性。与野生型蛋白相比,疾病相关的I2020T突变体在体外自磷酸化水平显著增加了约40%。这表明由I2020T突变引起的帕金森病病理学与LRRK2激酶活性的增加而非丧失有关。